Abstract #5599

High-resolution 1H MRS human plasma profiling of pancreatic ductal adenocarcinoma

Santosh K Bharti¹, Michael Goggins^2,3, and Zaver M Bhujwalla^1,3

¹JHU ICMIC Program, Division of Cancer Imaging Research, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, ²Departments of Pathology and Medicine, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, United States, ³Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

The dismally poor 5 year survival rate of less than 6% in pancreatic ductal adenocarcinoma (PDAC) increases to ~50% with early stage PDAC making early detection critically important. Metabolic characterization of patient plasma samples provides a unique opportunity to identify biomarkers to assist in routine screening to detect of PDAC. Here, in a preliminary study, we have characterized the metabolic profiles of plasma samples from normal, benign, and PDAC patients. Even with a limited sample we identified a significant increase in β-hydroxybutyrate, acetate, acetoacetate, lactate and pyruvate in PDAC compared to normal plasma.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.